![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Peregrine’s Brain Cancer Agent Shows Promise, Shares Up
Peregrine’s Brain Cancer Agent Shows Promise, Shares Up
September 2, 2009
Peregrine Pharmaceuticals Inc said its experimental brain cancer agent Cotara appeared well tolerated and showed encouraging signs of efficacy in a mid-stage trial, sending its shares up 21 percent in pre-market trade.
Forbes
Forbes
Upcoming Events
-
21Oct